News

Filter

Current filters:

Raptiva

1 to 9 of 104 results

PDL BioPharma swings to profit on cost-cuts

11-05-2009

USA-based biotechnology company PDL BioPharma swung to profit in the first quarter of 2009, compared…

AvastinbevacizumabEfalizumabHerceptinLucentisNatalizumabRanibizumab InjectionRaptivatrastuzumabTysabri

Stock Commentary - Europe - week to April 13, 2009

16-04-2009

EUROPEAN: bourses were mostly slightly higher in the Easter holiday-shortened reporting week to April…

AstraZenecaAventis PharmaEfalizumabGenentechGlaxoSmithKlineGSKMerck KGaAQuetiapine FumarateRaptivaRocheSanofi-AventisSeroquelShireSolvay

Genentech withdraws Raptiva from US market due to fatal cases of PML

09-04-2009

US biotechnology firm Genentech, full control of which has now been acquired by Swiss drug giant Roche,…

EfalizumabGenentechMerck KGaARaptivaRoche

Another PML case for Genentech's Raptiva

24-11-2008

US biotechnology giant Genentech has issued another Dear Healthcare Provider letter alerting physicians…

EfalizumabGenentechRaptiva

1 to 9 of 104 results

Back to top